Clerio Vision, founded on pioneering research from the University of Rochester, is a medical device company dedicated to revolutionizing the global ophthalmic market. Their core mission is to enhance vision care through innovative technology, specifically utilizing Laser Induced Refractive Index Change (LIRIC). This advanced technology aims to create optically superior lens patterns to correct various vision impairments such as presbyopia, myopia, hyperopia, astigmatism, and higher-order aberrations.
Notable affiliations include leading researchers and experts in ophthalmology and optics from the University of Rochester. Clerio Vision has garnered attention and investment from key players in the medical and tech industries. Their groundbreaking LIRIC technology has positioned them as a transformative force in vision correction, offering millions of patients superior alternatives to traditional methods. Through their innovative approach, Clerio Vision has significantly impacted the field of ophthalmology, setting new standards for vision care solutions.
